Navigation Links
Lilly CFO Derica Rice Assumes Expanded Responsibilities, Promoted to Executive Vice President
Date:12/18/2009

INDIANAPOLIS, Dec. 18 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY) today announced that Derica Rice, senior vice president and chief financial officer for Lilly, has assumed expanded responsibilities and has been promoted to executive vice president, global services and chief financial officer, effective January 1.

In this role, Rice will retain his responsibilities as chief financial officer of the company and add responsibility for global services, including the ongoing global services design project, as well as IT and Six Sigma.

"Derica has demonstrated strong leadership and outstanding results during his 19-year career at Lilly," said Lilly Chairman, President and CEO John Lechleiter, Ph.D. "Derica, in his new role, will help ensure that these important functions, aligned with our global services design effort, continue to provide needed support to our business units and our key functions in the most efficient and effective way possible."

Rice joined the company in 1990 as an international treasury associate. He has held numerous leadership roles during his tenure, including chief financial officer for Lilly Canada, executive director and chief financial officer for European operations based in London, and the general manager of Lilly United Kingdom and Republic of Ireland. Prior to becoming Lilly's CFO in 2006, Rice had been the vice president and controller since July 2003.

Born in Decatur, Alabama, Rice received a bachelor's degree in electrical engineering from Kettering University (formerly the GMI Engineering & Management Institute) in 1988 and a master's degree in business administration in 1990 from Indiana University.

In 2009, Rice was selected as one of the "Most Powerful Executives in Corporate America" by Black Enterprise magazine and he was s
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Lilly Declares First-Quarter 2010 Dividend
2. FDA Approves Lillys ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults
3. Lilly Outlines Innovation Strategy, Reviews Promising Pipeline of Potential Medicines and Sets 2010 Financial Guidance
4. FDA Approves Lillys Zyprexa for Two Adolescent Indications
5. Lilly Releases Latest Value of Medicine Resource Guide About Key Issues Facing the Pharmaceutical Industry
6. Lilly Surpasses United Way 2009 Campaign Goal
7. Dr. Steven M. Paul to Retire from Lilly as Executive Vice President, Science and Technology, President, Lilly Research Laboratories; Dr. Jan M. Lundberg, Executive Vice President, Head of Global Discovery Research, AstraZeneca, Named his Successor
8. Amylin Pharmaceuticals and Eli Lilly and Company Statement on FDAs BYETTA(R) (Exenatide) Injection Update
9. Lilly CEO Lechleiter Calls for Repair of the Engine of Biopharma Innovation
10. Eli Lilly and Company Opens Eco-Friendly Biotechnology Center on the West Coast Designed to Speed and Enhance Innovation
11. Lilly Surpasses Energy Efficiency Goals and Celebrates Worldwide Energy Day
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... , March 2, 2015 Nevro Corp. (NYSE: ... has developed and commercialized an innovative, evidence-based neuromodulation platform ... Brad Vale , PhD, DVM, former Head of ... to its Board of Directors, effective March 1, 2015. ... of experience in developing, commercializing and investing in innovative ...
(Date:3/2/2015)... WEST JORDAN, Utah , March 2, 2015 ... of Medical Imaging Solutions, has acquired Eclipse Systems, ... and customized service solutions. As part of their ... comprehensive service at an affordable rate, BC Technical ... strategic acquisition allows BC Technical to add valuable ...
(Date:3/2/2015)... 2, 2015  DURECT Corporation (Nasdaq: ... and the successful completion of a Phase 1 ... DUR-928.  DUR-928 is an endogenous, small-molecule, new chemical ... metabolic diseases such as nonalcoholic fatty liver disease ... organ injuries such as acute kidney injury (AKI).  ...
Breaking Medicine Technology:Nevro Appoints Dr. Brad Vale to its Board of Directors 2BC Technical Acquires Eclipse Systems 2DURECT Announces Epigenomic Regulator Program including a New NAFLD/NASH and Acute Organ Injury Product Candidate in Development 2DURECT Announces Epigenomic Regulator Program including a New NAFLD/NASH and Acute Organ Injury Product Candidate in Development 3DURECT Announces Epigenomic Regulator Program including a New NAFLD/NASH and Acute Organ Injury Product Candidate in Development 4DURECT Announces Epigenomic Regulator Program including a New NAFLD/NASH and Acute Organ Injury Product Candidate in Development 5
... Dec. 9, 2010 The national media keeps ringing the ... the NYU one-year research study on pediatric dosing instructions on ... the American Medical Association ,s December issue. The results are ... liquid medications, found inconsistencies across all the medications, with the ...
... Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH ), a ... with inflammation, today announced it will hold a conference ... and remediation plans relating to vial problems in the ... 2010Time: , 5:00 pm Eastern TimeDomestic Dial-in: , (877) ...
Cached Medicine Technology:AccuDial® Pharmaceutical Solves OTC Dosing Errors for Children's Liquid Medications 2AccuDial® Pharmaceutical Solves OTC Dosing Errors for Children's Liquid Medications 3Anthera Announces Update Call Regarding Vial Problems 2
(Date:3/2/2015)... Monroeville, PA (PRWEB) March 02, 2015 ... part of the Allegheny Health Network, are ... with new software called Visual Info Zonal Reminder (VIZR), ... , Introduced in 2013, Google Glass is a wearable ... in a smartphone-like hands-free format. Wearers communicate with the ...
(Date:3/2/2015)... CA (PRWEB) March 02, 2015 Ticket ... tickets at the Hollywood Bowl . This popular site ... customer appreciation promo code JIMMY-BUFFETT-2015 for added savings. , ... their favorite performer will be headlining at the Hollywood ... concert will be on Thursday, October 22nd and it ...
(Date:3/2/2015)... 02, 2015 Doctors in Novara, Italy ... better predictor of outcomes for people with mesothelioma than ... of the new study on the Surviving Mesothelioma ... University of Eastern Piedmont followed the cases of 172 ... for excess lung fluid. , “Persistent lung expansion ...
(Date:3/2/2015)... 02, 2015 Burns Engineering's Lab-to-Lab ... for Secondary Standard Platinum Resistance Thermometers (SSPRTs) and ... days or less . . . guaranteed. ... Accredited (Lab Code 200706-0), ISO 9001 and 17025 ... range is -196°C to 500°C, both ITS-90 and ...
(Date:3/2/2015)... The minimally invasive surgical instruments market ... 6.1% to reach $14,133.0 million by 2019 from ... as advantages of minimally invasive surgeries over traditional ... invasive surgeries and increasing number of surgical procedures ... minimally invasive surgical instruments market. , For More ...
Breaking Medicine News(10 mins):Health News:Pennsylvania Hospital Explores Use of Google Glass for Trauma Care 2Health News:Pennsylvania Hospital Explores Use of Google Glass for Trauma Care 3Health News:Cheap Jimmy Buffett Tickets Hollywood Bowl: Ticket Down Slashes Prices on Jimmy Buffett Tickets at the Hollywood Bowl in Los Angeles/Hollywood, CA 2Health News:New Research Links Talc Treatment Response with Mesothelioma Prognosis, According to Surviving Mesothelioma 2Health News:Burns Engineering Announces Quick-Turn Temperature Calibrations 2Health News:Minimally Invasive Surgical Instrument Market - Global Forecast to 2019 - New Report by MarketsandMarkets 2
... University may have isolated the substance most responsible// for ... a discovery that could revolututionise treatments for a host ... by Riyi Shi (REE-yee SHEE) has found that a ... high levels in spinal tissue for several days after ...
... who are being diagnosed for diabetes type 2 may ... the onset of the disease. ,A study done ... have shown that among the children who are newly ... five of them have showed tendencies of being afflicted ...
... to find out why the diabetes drug thiazolidinediones (TZDs) can ... found that the drug TZDs activates a receptor in kidney ... the collecting duct of the kidney. The activation of the ... causes edema. ,TZD drugs are generally used to lower ...
... the help of anti fungal medication itraconazole can reduce ... have broken new grounds in asthma treatment by using ... aspergillosis, which is a form of asthma. , ... with steroids or drugs that have equally disastrous side ...
... is trying new approaches to the neuroblastoma patients, researchers// ... more effective in children than the common procedure. ... that the cancer drug topotecancan must be fine tuned ... all doses are effective on everybody. Only less than ...
... placebo treatment can reduce the nature of emotional experience// ... treatment consists of dummy medication or intervention. This can ... injections etc. ,In the new research done by ... placebo treatment can effectively control the impact of negative ...
Cached Medicine News:Health News:Acrolein may be the key to halting spinal cord damage 2Health News:Acrolein may be the key to halting spinal cord damage 3Health News:Acrolein may be the key to halting spinal cord damage 4
Designed specifically for use with children ages,3 and up The patient is asked to distinguish between a "Raised E" and a non stereo target....
... The Standard for Stereo Depth ... to 1200 sec or arc) and ... Graded Circle Test (800 to 40 ... Children (400 to 100 sec of ...
... Emit 2000 Phenytoin Assay is ... for use in the quantitative ... serum or plasma. Kits are ... the Roche COBAS MIRA, COBAS ...
... The Emit 2000 Digoxin Assay ... intended for use in the ... human serum or plasma. Kits ... on the Roche COBAS MIRA, ...
Medicine Products: